EMBrACe – Patient empowerment through competence: reaching for health beyond the absence of cancer.
Not Applicable
Recruiting
- Conditions
- C81Hodgkin lymphoma
- Registration Number
- DRKS00032098
- Lead Sponsor
- niversitätsklinikum Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Histologically verified initial diagnosis of Hodgkin lymphoma
The patient is therapy-naïve with regard to HL
Written declaration of consent to participate in the study available
The patient agrees that the personal data will be made available to the study in compliance with data protection.
Exclusion Criteria
• Inability to communicate in German
• lack of compliance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective level of information measured with the total score of the EORTC QLQ-INFO25 questionnaire one year after the end of HL therapy
- Secondary Outcome Measures
Name Time Method